Algeria vs Venezuela: Cause of death, by non-communicable diseases, ages 0-4
Algeria
24.4%
in 2021
Venezuela
24.9%
in 2021
Algeria rank
114th
Venezuela rank
113th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Algeria
- Venezuela
How they compare
Venezuela currently reports 24.9% against 24.4% in Algeria, a difference of 0.5%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Venezuela ahead.
Algeria ranks 114th and Venezuela ranks 113th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and Venezuela in 2.
Head to head by decade
| Decade | Algeria | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.0% | 19.7% | 3.7% | Venezuela |
| 2010s | 24.1% | 22.6% | 1.5% | Algeria |
| 2020s | 24.5% | 24.9% | 0.4% | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Algeria or Venezuela?
- Venezuela, at 24.9% against 24.4% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Algeria and Venezuela?
- 0.5%, with Venezuela ahead.
- How many years of comparable data are there for Algeria and Venezuela?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Venezuela rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Algeria ranks 114th and Venezuela ranks 113th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.